Qing-Xin-Jie-Yu Granule Attenuates Myocardial Infarction-induced Inflammatory Response by Regulating the MK2/TTP Pathway

Overview

Journal Pharm Biol

Specialties Pharmacology
Pharmacy

Date 2025 Feb 21

PMID 39980416

Authors

Jianghan Qi

Xiaoyao Gao

Ying Han

Meiling Yang

Chenyi Wei

Ling Zhang

Jianfeng Chu

Affiliations

Soon will be listed here.

Abstract

Context: Qing-Xin-Jie-Yu Granule (QXJYG) has shown promise in the treatment of myocardial infarction. However, the mechanism of action of QXJYG underlying its anti-inflammation remain unknown.

Objective: The study aimed to evaluate the effectiveness and mechanism of QXJYG in a mouse model of myocardial infarction and hypoxia-induced H9C2 cells.

Materials And Methods: Myocardial infarction was induced in mice left anterior descending coronary artery ligation, and hypoxia-induced H9C2 cells was served as the model. The cardiac function was evaluated by echocardiography, while myocardial tissue pathology was examined using HE and Masson's trichrome staining. Changes in serum markers of cardiac injury were measured using ELISA kits. The levels of inflammatory cytokines in both the serum and cardiac tissue were quantified using the Bio-Plex Pro Mouse Chemokine assay, and hypoxia-induced inflammatory factors in H9C2 cells were assessed by RT-qPCR. Additionally, western blot analysis was conducted to evaluate the expression of proteins related to the MK2/TTP signaling pathway both and experiments.

Results: QXJYG significantly enhanced cardiac function in mice with myocardial infarction, as evidenced by improved myocardial tissue structure, reduced collagen fiber deposition, and lowered serum levels of creatine kinase isoenzyme MB (CK-MB), cardiac Troponin T (cTnT), and brain Natriuretic Peptide (BNP). QXJYG may reduce the expression of inflammatory factors in both the heart and serum of myocardial infarction-induced mice and attenuate hypoxia-induced levels of inflammatory factors in cardiomyocytes by decreasing the ratio of p-MK2/MK2 and increasing the protein expression of TTP.

Discussion And Conclusions: QXJYG improved cardiac function and reduced injury, fibrosis, and inflammation after myocardial infarction, likely through modulation of the MK2/TTP signaling pathway.

References

Xu H, Shi D, Yin H . [Blood-stasis and toxin causing catastrophe hypothesis and acute cardiovascular events: proposal of the hypothesis and its clinical significance]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009; 28(10):934-8. View

Mahtani K, Brook M, Dean J, Sully G, Saklatvala J, Clark A . Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol. 2001; 21(19):6461-9. PMC: 99793. DOI: 10.1128/MCB.21.9.6461-6469.2001. View

Sandler H, Kreth J, Timmers H, Stoecklin G . Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res. 2011; 39(10):4373-86. PMC: 3105394. DOI: 10.1093/nar/gkr011. View

Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber A, Radzioch D . Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol. 2006; 26(6):2399-407. PMC: 1430282. DOI: 10.1128/MCB.26.6.2399-2407.2006. View

Streicher J, Ren S, Herschman H, Wang Y . MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res. 2010; 106(8):1434-43. PMC: 2903446. DOI: 10.1161/CIRCRESAHA.109.213199. View

Lei W, Li X, Li L, Huang M, Cao Y, Sun X . Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways. J Ethnopharmacol. 2021; 281:114438. DOI: 10.1016/j.jep.2021.114438. View

Reboll M, Korf-Klingebiel M, Klede S, Polten F, Brinkmann E, Reimann I . EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction. Circulation. 2017; 136(19):1809-1823. DOI: 10.1161/CIRCULATIONAHA.117.029980. View

Bak R, Mikkelsen J . Regulation of cytokines by small RNAs during skin inflammation. J Biomed Sci. 2010; 17:53. PMC: 2905360. DOI: 10.1186/1423-0127-17-53. View

Cheng J, Ren C, Cheng R, Li Y, Liu P, Wang W . Mangiferin ameliorates cardiac fibrosis in D-galactose-induced aging rats by inhibiting TGF-β/p38/MK2 signaling pathway. Korean J Physiol Pharmacol. 2021; 25(2):131-137. PMC: 7893489. DOI: 10.4196/kjpp.2021.25.2.131. View

10.

Chang X, Zhang Q, Huang Y, Liu J, Wang Y, Guan X . Quercetin inhibits necroptosis in cardiomyocytes after ischemia-reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control. Phytother Res. 2024; 38(5):2496-2517. DOI: 10.1002/ptr.8177. View

11.

Nakano A, Baines C, Kim S, Pelech S, Downey J, Cohen M . Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res. 2000; 86(2):144-51. DOI: 10.1161/01.res.86.2.144. View

12.

Lee T, Hamilton M, Stevenson L, Moriguchi J, Fonarow G, Child J . Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol. 1993; 72(9):672-6. DOI: 10.1016/0002-9149(93)90883-e. View

13.

Xiong W, Feng S, Wang H, Qing S, Yang Y, Zhao Y . Identification of candidate genes and pathways in limonin-mediated cardiac repair after myocardial infarction. Biomed Pharmacother. 2021; 142:112088. DOI: 10.1016/j.biopha.2021.112088. View

14.

Ke D, Ni J, Yuan Y, Cao M, Chen S, Zhou H . Identification and Validation of Hub Genes Related to Neutrophil Extracellular Traps-Mediated Cell Damage During Myocardial Infarction. J Inflamm Res. 2024; 17:617-637. PMC: 10844013. DOI: 10.2147/JIR.S444975. View

15.

Chang X, Li Y, Liu J, Wang Y, Guan X, Wu Q . ß-tubulin contributes to Tongyang Huoxue decoction-induced protection against hypoxia/reoxygenation-induced injury of sinoatrial node cells through SIRT1-mediated regulation of mitochondrial quality surveillance. Phytomedicine. 2022; 108:154502. DOI: 10.1016/j.phymed.2022.154502. View

16.

Pan W, Zhou G, Hu M, Li G, Zhang M, Yang H . Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway. BMC Cardiovasc Disord. 2024; 24(1):76. PMC: 10822151. DOI: 10.1186/s12872-024-03729-x. View

17.

Li Z, Lin C, Cai X, Hu S, Lv F, Yang W . Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis. 2023; 379:117181. DOI: 10.1016/j.atherosclerosis.2023.06.972. View

18.

Ronkina N, Menon M, Schwermann J, Tiedje C, Hitti E, Kotlyarov A . MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Biochem Pharmacol. 2010; 80(12):1915-20. DOI: 10.1016/j.bcp.2010.06.021. View

19.

Wang X, Guo Z, Ding Z, Mehta J . Inflammation, Autophagy, and Apoptosis After Myocardial Infarction. J Am Heart Assoc. 2018; 7(9). PMC: 6015297. DOI: 10.1161/JAHA.117.008024. View

20.

Frangogiannis N . The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014; 11(5):255-65. PMC: 4407144. DOI: 10.1038/nrcardio.2014.28. View